Company news

GSK plc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

IDMC recommends gepotidacin early efficacy stop

November 3, 2022

GSK RSV vaccine: US FDA Priority Review

November 2, 2022

EMA validates MAA for cabotegravir LA for PrEP

October 28, 2022

EMA accepts GSK RSV older adult vaccine for review

October 28, 2022

GSK announces FDA meeting outcome on daprodustat

October 27, 2022

ContRAst phase III programme for otilimab update

October 27, 2022

Board Committee Changes

October 25, 2022

RSV older adult vaccine submission in Japan

October 21, 2022

Menveo new single-vial approved by US FDA

October 17, 2022

Efficacy results for GSK's older adult RSV vaccine

October 13, 2022

US FDA approves Boostrix maternal immunisation

October 10, 2022

GSK Chief Financial Officer succession

September 26, 2022

US FDA ODAC review of Zejula Phase III NOVA trial

September 22, 2022

GSK and Spero Therapeutics licence for tebipenem

September 22, 2022

GSK provides update on FDA review of daprodustat

September 6, 2022

GSK Board changes

August 24, 2022

Statement: Zantac (ranitidine) litigation update

August 17, 2022

FDA New Drug Application File Acceptance for MMB

August 17, 2022

GSK completes acquisition of Affinivax, Inc.

August 16, 2022

GSK Board change

July 29, 2022

Completion of GSK Share Consolidation

July 19, 2022

Haleon demerger completion and share consolidation

July 18, 2022

Result of General Meeting

July 6, 2022

GSK disclose discontinued operations from Q2 2022

July 5, 2022

GSK completes acquisition of Sierra Oncology

July 1, 2022

GSK files Shingrix 18+ at risk indication in Japan

June 28, 2022

Positive phase III data for GSK's RSV OA vaccine

June 10, 2022

Hardman & Co Life Sciences Research: Long-t...

June 7, 2022

US FDA approval of Priorix

June 6, 2022

Demerger update: Publication of Documents

June 1, 2022

Demerger update: Submission of Documents to FCA

June 1, 2022

GSK to acquire Affinivax, Inc.

May 31, 2022

Further appointments to Designate Haleon Board

May 30, 2022

GSK Cervarix two-dose schedule approved by NMPA

May 27, 2022

Iain Mackay - External Appointment

May 19, 2022

Change of name to GSK plc

May 16, 2022

Daprodustat application accepted for review by FDA

April 19, 2022

GSK agrees to acquire Sierra Oncology for $1.9bn

April 13, 2022

GSK - segment and product sales reporting changes

April 1, 2022

Publication of 2022 AGM Notice

March 28, 2022

FDA update: Cabenuva oral lead-in now optional

March 24, 2022

Issuance of Notes

March 23, 2022

Appointments to Designate Haleon Board

March 15, 2022

GSK Annual Report 2021 on Form 20-F

March 8, 2022

GSK publishes Annual Report 2021

March 4, 2022

Daprodustat application accepted for review by EMA

March 1, 2022

GSK introduces Haleon to investors

February 28, 2022

GSK RSV maternal vaccine candidate further update

February 28, 2022

Canada Approval For Medicago GSK Covid-19 Vaccine

February 24, 2022

GSK Consumer Healthcare to be called Haleon

February 22, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 27 calls. Every call is listed under its year.

Decks

The 5 newest of 182 decks. Every deck is listed under its year.